Bicara Therapeutics Newsroom

Stifel Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $47

Futu NewsNov 13 21:38

Morgan Stanley Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $36

Futu NewsNov 13 21:38

TD Cowen Maintains Bicara Therapeutics(BCAX.US) With Buy Rating

Futu NewsNov 13 21:36

Morgan Stanley Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Raises Target Price to $36

Futu NewsNov 13 20:36

TD Cowen Maintains Bicara Therapeutics(BCAX.US) With Buy Rating

Futu NewsNov 13 04:30

Promising Prospects for Bicara Therapeutics: Buy Rating on Ficerafusp's Innovative Approach

TipRanksNov 13 03:42

Rodman & Renshaw Initiates Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $48

Futu NewsNov 5 20:34

Bicara Therapeutics Initiated at Overweight by Morgan Stanley

Dow JonesOct 8 19:35

Bicara Therapeutics Analyst Ratings

BenzingaOct 8 19:22

TD Cowen Initiates Bicara Therapeutics(BCAX.US) With Buy Rating

Futu NewsOct 8 18:31

Stifel Initiates Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $47

Futu NewsOct 8 18:31

Morgan Stanley Initiates Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $35

Futu NewsOct 8 17:34

Bicara Therapeutics: A Buy Rating on Promising Clinical Progress and Financial Fortitude

TipRanksOct 8 17:20